
    
      This is a single-arm, non-randomized study designed to assess the preliminary safety and
      clinical performance of the NuPulseCV iVAS.

      Data obtained from the study will be used to make device modifications, refine the patient
      population, and inform the design a future clinical trial suitable for assessing longer-term
      use in heart failure patients.
    
  